Manufacturer record
Caplet India Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Caplet India Pvt. Ltd (West Bengal) were declared Not of Standard Quality between July 2020 and October 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: AML3035, Ambroxol Hydrochloride Solution 100 ml (exp Jun 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Description. Listed in the October 2023 alert.
Records by type
3 records linked to Caplet India Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride Solution 100 ml | Batch AML3035Mfg Jul 2023 · Exp Jun 2025 | DescriptionDescription | CDL KolkataCDSCO lab | Oct 2023 |
| Dispersible Amoxycillin Tablets I.P. 125 mg | Batch AXT 11072Mfg Dec 2021 · Exp Nov 2023 | Uniformity of DispersionUniformity of weight/content | CDL KolkataCDSCO lab | Aug 2022 |
| Pantoprazole Tablets I.P. 40 mg | Batch PNT94087Mfg Sep 2019 · Exp Aug 2021 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.